Trial Profile
A Double-Blind, Multicenter, Randomized Study Evaluating the Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Relationship in T2DMs Treated With 14 Weeks Injection of Polyethylene Glycol Loxenatide
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Oct 2013
Price :
$35
*
At a glance
- Drugs Pegloxenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 29 Oct 2013 New trial record